Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor protein-tyrosine kinase erbB-3 (ERBB3/HER3) is a member of the epidermal growth factor receptor (EGFR/ERBB) family. It is a receptor tyrosine kinase that, upon activation by neuregulins, primarily heterodimerizes with other ErbB receptors, most notably ErbB2/HER2, to activate downstream signaling pathways, particularly the PI3K/Akt pathway. While it possesses impaired kinase activity, it plays a crucial role in cell survival, proliferation, and drug resistance in various cancers, making it an important therapeutic target.
Heterodimerization with other ErbB receptors (primarily ErbB2/HER2) leading to activation of PI3K/Akt pathway.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor protein-tyrosine kinase erbB-3 (ERBB3).